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Abstract
Access to secondary specialist services is important for women with suspected uterine cancer. Shorter waiting
times lead to earlier diagnosis and improved outcomes. This study compared waiting times for 147 women
attending 2 hospitals using different booking systems. The clinic-based booking system resulted in shorter
waiting times compared with centralized booking. Both systems failed to meet guidelines for waiting times.
Background: A 2-week waiting time from primary care referral to ﬁrst specialist assessment is recommended for
patients with symptoms of suspected cancer, such as post-menopausal bleeding (PMB). We compared 2 different
booking systems in relation to the observed waiting time for patients with suspected uterine cancer. Methods: Data
were collected concurrently between July 2009 and August 2010, and captured the duration of waiting time from
referral to specialist assessment for each woman with PMB. A comparison of 2 outpatient booking systems on waiting
times was undertaken for 2 District Health Boards (DHBs) in New Zealand. DHB1 uses a centralized booking system,
and DHB2 uses a clinic-based system. Results: A total of 147 women were included in the timing analysis. At DHB1,
2 of 90 women (2%) were seen within 2 weeks and 61 of 90 women (68%) waited more than 42 days. At DHB2, 24 of
57 women (42%) were seen within 2 weeks and 19 of 57 women (33%) waited more than 42 days. Overall, only 18% of
women in this study were seen within the 2-week time-frame and 80 of 147 women (54%) waited more than 42 days
from referral to specialist assessment. Conclusions: In this study, a clinic-based booking system was associated with
shorter waiting times compared with a centralized booking system in 2 reasonably comparable DHB services. Waiting
times were longer than the recommended guidelines, regardless of booking system. Further research is needed to
clarify the effects of these different booking systems on waiting times.
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Suspected cancer symptoms warrant urgent review for prognostic
and psychologic reasons.1,2 Secondary health services in many
public health systems typically receive referrals from general prac-
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booked for a ﬁrst assessment via an appropriate specialist.3-5 The
effective and timely management of referrals is commonly recog-
nized as dependent on demand for the services and the capacity of
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Waiting Times for Investigation of Suspected CancerPost-menopausal bleeding (PMB) is a cardinal symptom of sus-
pected cancer of the female reproductive tract and the most com-
mon presenting symptom for uterine cancer.7 The current
recommended time in the United Kingdom for suspected cancer
from the initial GP referral to outpatients to the commencement of
deﬁnitive treatment is 62 days or less.8
UK referral guidelines for suspected cancer recommend that
women with PMB are seen for ﬁrst specialist assessment by sec-
ondary gynecology services within 2 weeks of a referral from primary
care.1 Although there is limited evidence to support the 2-week
referral recommendation,9 this standard for all suspected cancers
has been accepted as necessary if the maximal 62-day wait time to
deﬁnitive treatment is to be consistently achieved.8 In New Zealand,
the United Kingdom, and other developed countries, uterine cancer
is the second most commonly occurring gynecologic cancer (after
ovarian cancer) with the incidence increasing with age.10-12 As in the
United Kingdom, women with PMB are referred for specialist
assessment with a gynecologist by their GP to the public hospital
where treatment is free or privately where a patient fee applies.13
Current guidelines in New Zealand also recommend a specialist
gynecology assessment for PMB within 2 weeks of referral.14
In New Zealand, District Health Boards (DHBs) are responsible
for provision of both primary and secondary health service delivery
to deﬁned geographic populations.15 Two forms of booking system
are in use: (1) centralized booking systems (where outpatient
referrals to all of a hospital’s secondary services are received and
distributed for triage, and appointments are subsequently allocated
in a central location); and (2) clinic booking system (where
outpatient referrals are sent directly to the relevant clinic and
specialty-speciﬁc administrators and clinicians run outpatient clinics
and receive and triage referrals, and book specialist assessment
appointments). There are few comparative data regarding central-
ized vs. clinic booking with respect to referrals for suspected cancers.
This study compared the timeliness of patients with PMB
proceeding from GP referral to ﬁrst specialist assessment at 2 DHBs
in New Zealand that use a centralized or clinic-based booking system.
Materials and Methods
A retrospective cohort design was used to examine waiting times
for the investigation of PMB between July 1, 2009, and September
1, 2010. The progress of post-menopausal women with vaginal
bleeding was tracked from the time of specialist assessment back to
their ﬁrst medical visit with their GP for PMB by patient interviews
and clinical notes search. Ethical approval for the study was granted
by the New Zealand Central Regional Ethics Committee (Ref:
CEN/08/09/044). This study is based on an analysis of subset of
data from a larger study designed to look at the patient journey from
the time a woman ﬁrst experienced PMB until her ﬁrst specialist
appointment and subsequent interactions with health services.
Setting and Booking System
This study was conducted in 2 geographically adjacent DHBs
in New Zealand. Although DHB1 serves a bigger population
than DHB2 (DHB1 291,300; DHB2 143,700),16 population
demographics are comparable with respect to age, gender, and
ethnicity,17 and ease of physical access. DHB1 used a centralized
booking system and had gynecological clinics based at 3 sites. DHB2Clinical Ovarian and Other Gynecologic Cancer December 2012used a clinic-based booking system serving 1 site. New PMB
referrals were considered to warrant an urgent appointment to the
secondary gynecology service in both DHBs. There are no dedicated
PMB clinics at either DHB, and both ﬁrst-time and follow-up ap-
pointments are managed by the gynecological clinics at the 2 DHBs.
For both DHBs, urgent referrals received priority for clinic time.
During the study period, DHB1 had approximately 26 hours and
DHB2 had 15 hours per week of clinic time available. When ad-
justed per 10,000 head of population, DHB1 had approximately
43 hours of clinic time per year (26 hours/week  48 weeks ¼
1248 hours) and DHB2 had approximately 50 hours of clinic time
per year (personal communication with DHB clinic managers, 2011).
Study Population
The study population included all women who attended their
specialist assessment, after GP referral for PMB, at each of the 2
DHBs. Eligibility criteria included the following: referred for
investigation of PBM and women deemed by hospital staff to be able
to participate in a 30-minute interview. PMB was deﬁned as vaginal
bleeding occurring 12 months or more after the ﬁnal menstrual
bleed. Written informed consent was obtained from each participant
for the interview and for access to the general practice patient notes,
and subsequent hospital notes pertaining to the PMB event. General
practice and hospital clinical notes were searched for date of referral
and date of specialist assessment. Data were also collected on missed
or changed appointments (patient or hospital initiated).
Information on ethnicity and socioeconomic status (New Zealand
Deprivation Index) was obtained for each participant from the New
Zealand Health Information Service. The New Zealand Deprivation
Index is a measure of socioeconomic status based on residential
dwellings, with scores ranging from 1 (least deprived) to 10 (most
deprived).18 Level of deprivation was determined by matching
individual National Health Index numbers to national health data-
sets. For the purposes of this study, we grouped NZDep06 scores
into 3 groups: 1 to 4, 5 to 6, and 7 to 10 giving low, medium, and
high levels of deprivation, respectively.
Analysis
Data were entered into a customized Access database (Microsoft
Corp, Redmond, WA), collated, checked, and veriﬁed. The analysis
of waiting times was undertaken for all study participants for whom
an accurate referral date could be established. A quality check of
every ﬁfth patient’s notes was undertaken to ensure that the date on
the referral letter was the same as the date the GP referral was
received by the hospital.
The primary outcome measure was the waiting time (in days)
from the date of GP referral to outpatients until the date women
were seen by the specialist for assessment. Waiting times were also
calculated as the proportion of participants seen within each of
4 time periods: (1) within 14 days, (2) 15 to 28 days, (3) 29 to
42 days, and (4) > 42 days after GP referral. Waiting times were
further analyzed in relation to patient age.
Data were analyzed using R 2.13.1 (R Foundation, Vienna,
Austria). KaplaneMeier survival curves (“survival” package in R)
were used to compare time from GP referral to the specialist
assessment according to DHB status, including analysis stratiﬁed by
age group. Median waiting times and 95% conﬁdence intervals were
Table 1 Patient Recruitment Outcomes in the Two DHBs
Recruitment
Outcomes
DHB1 DHB2 Totals
n Row % n Row % n Row %
Patients approached 133 62 80 38 213 100
Eligible 120 63 70 37 190 100
Consented 95 62 59 38 154 100
Included in analysis 90 61 57 39 147 100
Abbreviation: DHB ¼ District Health Board.
Table 2 Demographic Characteristics of Study Participants in the Two DHBs
Demographic
Characteristics
DHB1 (n [ 90) DHB2 (n [ 57) Total (n [ 147)
n % n % n %
Age band
< 65 years 65 72 41 72 106 72
 65 years 25 28 16 28 41 28
Ethnicitya
Maori 19 21 8 14 27 18
NZ European 50 56 41 72 91 62
Paciﬁc 7 8 4 7 11 7
Asian 3 3 1 2 4 3
Other 11 12 3 5 14 10
NZ Deprivation Index
1-4 (least deprived) 28 31 15 26 43 29
5-6 32 36 13 23 45 31
7-10 (most deprived) 26 29 25 44 51 35
Not available 4 4 4 7 8 5
Abbreviations: DHB ¼ District Health Board; NZ ¼ New Zealand.
aEthnicity was self-identiﬁed and collected using the 2001 New Zealand census question.
Beverley A. Lawton et alcalculated for the total sample and for participants recruited from
the 2 DHBs. Note that as patients were identiﬁed at the time of the
ﬁrst specialist assessment, these analyses contained no censored data
points (ie, all patients in the analysis had dates recorded for both
referral and specialist appointment, in contrast to most survival
analyses where “censored” individuals have not yet experienced the
event of interest).
Results
Recruitment
Of the 210 women approached to participate in the study, 190
(91%) were deemed eligible and 154 (73%) consented to participate
(Table 1). Of the 23 women deemed ineligible, 14 did not have PMB
and 5 were considered by DHB nursing staff as not able to answer the
questionnaire. Two were not well enough to participate, and 2 were
recorded twice. Analysis was completed for 95% of consenting
women (147/154). Seven participants were excluded from the anal-
ysis because of missing data on referral dates. Characteristics of the
study population in the 2 DHBs are presented in Table 2.
Waiting Times
For the majority of women, waiting times (from referral to ﬁrst
specialist assessment) for assessment of PMB were longer thanrecommended in current guidelines regardless of booking system.
Approximately more than half of all women in the study (80/147;
54%) waited more than 42 days, 3 times as long as recommended.
Waiting times are presented in Table 3 stratiﬁed by age for the
2 DHBs (Table 3).
In most cases, there was little delay between the date on the GP’s
referral letter and the receipt of the referral by the hospital by fax or
electronically. Referrals were posted in a few cases (DHB1 ¼ 8;
DHB2 ¼ 2), and this created some time delays. Nineteen women
had appointment time changes by the hospital or the patient. For
16 of 19 women (84%), appointment time changes further
contributed to the waiting time. All but 2 of the 19 changed
appointment times occurred at DHB1; half of these were hospital-
initiated changes.
Patients at DHB1 were more likely to have a delay in being seen
compared with DHB2. Time to specialist assessment appointment
was estimated using KaplaneMeier curve methods and formally
compared between DHBs. As shown in Figure 1, waiting time to
specialist assessment was longer in DHB1 (median, 53 days; 95%
CI, 49-57) than in DHB2 (median, 18 days; 95% CI, 12-26), log-
rank c2 (1 degree of freedom [df] ¼ 6.1, P ¼ .014).
Figure 2 presents KaplaneMeier survival curves for time from
referral to specialist assessment appointments for the 2 DHBs,Clinical Ovarian and Other Gynecologic Cancer December 2012 - 89
Table 3 Waiting Times From Referral to Specialist Appointment for Participants in the Two DHBs Stratiﬁed by Age-Band
Age Band
Time to
Appointment
DHB1 (n [ 90) DHB2 (n [ 57) Total (n [ 147)
n % n % n %
< 65 years  14 d 1 2 15 37 16 15
15-28 d 4 6 10 24 14 13
29-42 d 14 22 1 2 15 14
 43 d 46 71 15 37 61 58
Totals 65 100 41 100 106 100
 65 years  14 d 1 4 9 56 10 24
15-28 d 5 20 3 19 8 20
29-42 d 4 16 0 0 4 10
 43 d 15 60 4 25 19 46
Totals 25 100 16 100 41 100
All ages  14 d 2 2 24 42 26 18
15-28 d 9 10 13 23 22 15
29-42 d 18 20 1 2 19 13
 43 d 61 68 19 33 80 54
Totals 90 100 57 100 147 100
Abbreviation: DHB ¼ District Health Board.
Figure 1 Time (in Days) From Referral to First Specialist
Appointment According to DHB
Abbreviation: DHB ¼ District Health Board.
Figure 2 Time (in Days) From Referral to First Specialist
Appointment by Age Group (65D, < 65 Years)
According to DHB of First Specialist Appointment
Service
Abbreviation: DHB ¼ District Health Board.
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90 -divided by age group ( 65 vs. < 65 years). Women aged < 65
years appeared to wait longer than 42 days compared with women
aged  65 years in both DHBs (Table 3, Fig. 2), but this difference
was not signiﬁcant, log-rank c2 (1 df ) ¼ 0.5, P ¼ .494. Differences
in time from referral to ﬁrst specialist assessment were still apparent
between DHBs when these analyses were stratiﬁed for age, log-rank
c2 (1 df ) ¼ 5.7, P ¼ .017.
The steps in the referral pathway from GP referral to specialist
assessment is represented in Figure 3 by steps c, d, e, and f. In
DHB1 (centralized booking system), step c required information to
be transferred from the centralized booking ofﬁce to a clinic-basedClinical Ovarian and Other Gynecologic Cancer December 2012specialist gynecologist to complete step d and returned before the
central ofﬁce could complete step e. By contrast, in DHB2 (clinic-
based booking system) steps d and e and steps f and g were
completed in one location. In addition, in DHB2, triage of referrals
by the gynecologist occurred electronically, where gynecology clinic
staff were able to place referrals in gynecologists’ electronic inboxes
to be triaged at any time and from multiple locations, for example,
between theatre cases. The gynecologist could then forward all ur-
gent referrals electronically to the gynecology clinic nurses who
would ring the patient within 24 hours and make an appointment.
Figure 3 Steps in Referral Pathway for Suspected Gynecologic Cancer Using 2 Different Booking Systems
Abbreviation: DHB ¼ District Health Board.
Beverley A. Lawton et alDiscussion
Our study has found a statistically signiﬁcant difference in
waiting times between the 2 DHBs with different booking systems.
At DHB1, 2 of 90 women (2%) were seen within 2 weeks and 61 of
90 women (68%) waited more than 42 days. At DHB2, 24 of 57
women (42%) were seen within 2 weeks and 19 of 57 women
(33%) waited more than 42 days. However, overall only 18% of
women in this study were seen within the 2-week recommended
time-frame and 80 of 147 women (54%) waited more than 42 days
from referral to specialist assessment.
Our ﬁndings are consistent with those in at least one other New
Zealand region using a clinic-based booking system pathway.13
Previous simulation experiments have shown that pooling all re-
ferrals to a service for next available allocation rather than to indi-
vidual specialists reduces waiting times between GP referral and
specialist assessment.5 Both DHBs in this study were already using
pooled allocation systems; without this, waiting times may have
been even longer.
In the United Kingdom, the 2-week target for PMB has proved
difﬁcult to achieve through routine referral processes.19-21 Withsuspected breast cancer, attempting to reach this 2-week target using
routine referral can risk women with atypical symptoms being
classed as low priority.22 Appointment-driven booking systems are
prone to develop long waiting times whenever there is a mismatch
between capacity and demand;23 hospital booking systems exem-
plify such problems. A booking system is a pathway of adminis-
trative steps carried out by more than 1 person in more than 1
location. The more administrative steps that occur in the referral to
assessment pathway, the more likely it is that there will be longer
waiting times and the less efﬁcient the process.
Centralized booking systems have been introduced in many
hospitals as being more efﬁcient, but we have found the opposite.
We postulate that each step in the referral to assessment pathway
has the potential to act as an additional barrier to prompt investi-
gation and timely treatment, especially if each step is undertaken by
different people. In this study, the clinic-based system had the same
team members being responsible for most steps in the booking
process; it is possible that the clinic team’s shared goals and values
were an additional factor that positively inﬂuenced their booking
system process.Clinical Ovarian and Other Gynecologic Cancer December 2012 - 91
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92 -In addition to reduced waiting time, our results indicate that a
clinic-based system where phoning to book an appointment directly
with the patient resulted in reduced rebooking rates, likely because
of the increased patient choice regarding appointment times at the
time of initial booking. Other studies have shown that “direct”
booking systems with increased patient choice reduce waiting times
to specialist assessment with no reduction in quality,24,25 but they
require careful attention to be successful.26
Study Strengths and Limitations
Strengths of the study include the proportionally high participation
rates (with similar participation rates in the 2 DHBs). In addition,
any variation in external inﬂuences (eg, health campaigns) on the
study results is likely mitigated by the close proximity of the 2 DHBs.
Although the study results suggest that differences in the booking
system pathways may account for some of the signiﬁcant discrep-
ancy in waiting times between the 2 DHBs, the study was limited in
its ability to provide more detailed information about demand and
capacity during the study period. We cannot discount that the
differences in booking times may simply represent differences along
the spectrum of efﬁciency. Behavioral aspects, such as an increased
sense of patient engagement and staff engagement, may contribute
to the differences found. Further research into New Zealand
booking system pathways for urgent referrals is needed. The sample
size was too small to perform statistical analyses to investigate
whether patient characteristics (other than age) were signiﬁcantly
related to waiting times. Other patient characteristics that might
affect the timeliness of appointments, for example, transient living
arrangements or inaccurately recorded contact details, could not be
investigated in this study, although there is no obvious reason to
expect these characteristics to differ across the 2 DHB populations.
Finally, future studies should include data from a wider set of DHBs
using different booking systems, which will strengthen the validity
and generalizability of results regarding the impact of booking sys-
tem on the timeliness of investigations.27
Conclusions
Under the conditions evaluated, and notwithstanding some likely
differences in capacity, clinic-based booking was associated with
shorter waiting times. The type of booking system plays a major
role, and timeliness is further inﬂuenced by individuals’ health be-
haviors and socioeconomic factors, for example, barriers to primary
care. In New Zealand, there is a government focus to reduce waiting
times, particularly in the treatment of cancer.28 Further assessment
and identiﬁcation of the steps on the referral-assessment pathway
that can be combined or eliminated have the potential to reduce
waiting times for those with suspected cancer and would warrant
further investigation. A costebeneﬁt analysis of the different sys-
tems would be useful. Regardless of booking system, our results
have shown that the achievement of recommended 2-week waiting
times from primary care referral to ﬁrst specialist assessment is
challenging.
Clinical Practice Points
 What is already known about this subject? Endometrial carci-
noma is the second most common gynecologic malignancy, and
95% of women with endometrial carcinoma present with PMB.Clinical Ovarian and Other Gynecologic Cancer December 2012Referral guidelines (United Kingdom, New Zealand) recom-
mend that all women with PMB be seen at a specialist gyne-
cology clinic within 2 weeks of referral. The effective and timely
management of referrals from primary to secondary care is an
important component of improving cancer outcomes.
 What are the new ﬁndings? This study compared the referral
with ﬁrst specialist appointment waiting times for referrals for
PMB in 2 DHBs—one using a clinic-based booking system and
one using a centralized booking system. The clinic-based
booking system was associated with shorter waiting times for
referrals compared with a centralized booking system. Of
concern, waiting times for both systems exceeded the recom-
mended guidelines for the majority of women.
 How might it affect clinical practice in the foreseeable future? If
further research supports these ﬁndings, there is a stronger
mandate for hospitals in this country to move toward clinic-
based booking systems. Reducing the number of steps might
make the process more efﬁcient and thereby reduce the waiting
times and improve outcomes of women with suspected cancer.
Ongoing monitoring of waiting time performance should occur
as a quality measure.Acknowledgments
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